Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Biovaxys Technology
Biovaxys Technology logo

BIOV - Biovaxys Technology Reuters News

C$0.56 0.1  9.8%

Last Trade - 26/02/21

Sector
Healthcare
RiskRating
Highly Speculative
Size
Micro Cap
Style
Style Neutral
Market Cap £22.5m
Enterprise Value £22.1m
Revenue £n/a
Position in Universe 1243rd / 2684
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions BIOV Dividends
Reuters News
All News Reuters News Company Announcements
BRIEF-Biovaxys And Bioelpida Sign Term Sheet For Clinical Grade Bvx-0918A Bio-Production
18th Feb News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.